- AU$39.12m
- AU$38.09m
- AU$15.77m
Australia's Resonance Health gains on IAG agreement
Brief: Resonance Health Enters Global Strategic Alliance & MSA With Image Analysis Group
Brief: Resonance Health Posts Profit Attributable Of A$1.5 Million
Brief: Resonance Health Says It Expects FY27 Normalised EBITDA Of AUD 2.6 To 3.6 Million
Australia's Resonance Health jumps on FY26 forecast hike
Brief: Resonance Health Expects FY26 Underlying EBITDA A$2.6 Mln
Brief: Resonance Health Says Martin Blake Retires As Chair
Brief: Resonance Health Contracted For Clinical Drug Trial Worth A$13.775 Mln
Brief: Resonance Seeks Trading Halt Pending Announcement On Execution Of Contract For Services For Clinical Trial By Pharma Co
Australia's Resonance Health jumps on over 3-fold rise in FY24 earnings
Brief: Resonance Health Announces Expansion Of Its Trialswest Business In Western Australia
Brief: Resonance Health Posts 1HFY24 Revenue Of A$3.26 Mln
Brief: Resonance Health Says acquisition of TrialsWest Group
Brief: Resonance Health Seeks Trading Halt
Brief: Resonance Health Says Benjamin Carruthers Appointed As CFO
Australia's Resonance Health jumps most in 1-1/2 years on drug trial deal
Brief: Resonance Health Contracted For Clinical Drug Trial Worth A$6.33 Million Over 18 Months
Brief: Resonance Health Seeks Trading Halt
Brief: Resonance Health Says Hepafatsmart Cleared By US FDA